Technology News All about technology

18Jan/140

Global Melanoma Therapeutics Market 2012-2016

London (PRWEB) October 29, 2013

TechNavio analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.83 percent over the period 2012-2016. One of the key factors contributing to this market growth is the availability of new promising drugs in the pipeline. The Global Melanoma Therapeutics market has also been witnessing the increasing use of combination therapies for the treatment of melanoma. However, the availability of alternative treatment options could pose a challenge to the growth of this market.

TechNavio's report, the Global Melanoma Therapeutics market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Melanoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Bristol-Myers Squibb Co., Merck and Co. Inc., and F. Hoffmann-La Roche Ltd.

The Other vendors mentioned in the report are AB Science S.A., Amgen Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co. Ltd., GlaxoSmithKline plc, Pfizer Inc., and Vical Inc.

Key questions answered in this report:

What will the market size be in 2016 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Methodology

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

Market Research Process

Research Design

Research Methodology

5. Scope of the Report

Market Overview

Product Offerings

6. Market Landscape

Market Size and Forecast

6.1. Five Force Analysis

7. Melanoma Therapeutics Drugs in Pipeline

8. Geographical Segmentation

9. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

16.1. Bristol-Myers Squibb Co.

16.1.1. Business Overview

16.1.2. Key Information

16.1.3. SWOT Analysis

16.2. F. Hoffmann-La Roche Ltd.

16.2.1. Business Overview

16.2.2. Business Segmentation

16.2.3. Key Information

16.2.4. SWOT Analysis

16.3. Merck & Co. Inc.

16.3.1. Business Overview

16.3.2. Business Segmentation

16.3.3. Key Information

16.3.4. SWOT Analysis

17. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology

Exhibit 2: Global Melanoma Therapeutics Market 2012-2016 (US$ million)

Exhibit 3: Global Melanoma Therapeutics Market by Geographical Segmentation 2012

Exhibit 4: Global Melanoma Therapeutics Market by Vendor Segmentation 2012

Exhibit 5: Business Segmentation of F. Hoffmann-La Roche Ltd.

Exhibit 6: Business Segmentation of Merck and Co. Inc.

Read the full report:

Global Melanoma Therapeutics Market 2012-2016

http://www.reportbuyer.com/pharma_healthcare/treatments/global_melanoma_therapeutics_market_2012_2016_2.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/







Comments (0) Trackbacks (0)

No comments yet.


Leave a comment

No trackbacks yet.